IRCT20200105046010N7尚未招募未知
In- Vivo Bioequivalence study of Esmoprazole 40mg Cap. Kooshan Pharmed. Co. (Eosoflux) with brand drugs (Nexium® 40mg Cap., AstraZeneca, UK) in Iranian healthy volunteers.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General health(liver, heart, kidney)
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test of Ibuprofen tablet 800 mg Mofid Pharma with brand drug (Nexium ® 10 mg Sachet, AstraZeneca, UK)IRCT20200105046010N71Teb Mofid Nikan Pharmaceutical Co.24
招募中
Unknown
Bioequivalence study of tablets of Esomeprazole 40 mgIRCT20230222057495N17Koushan Pharmed Pharmaceutical Company24
尚未招募
4 期
Bioequivalence study of esomeprazole 20 mg (Capsule vs Tablet) in healthy Thai volunteers under fasting and fed conditionsHealthy volunteersTCTR20201125002Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University89
招募中
Unknown
Investigating bioequivalence of Omeprazole capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N16Tabriz University of Medical Sciences24
招募中
Unknown
Comparison of esomeprazole and fexuprazan in gastroesophageal reflux diseaseDiseases of the digestive systemKCT0008531Dongguk University Ilsan Hospital40